Koyfin Home > Directory > Health Care > Iovance Biotherapeutics Inc > EV / EBITDA (ltm)

Iovance Biotherapeutics Inc EV / EBITDA (ltm) Chart (IOVA)

Iovance Biotherapeutics Inc annual/quarterly EV / EBITDA (ltm) from 2020 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Iovance Biotherapeutics Inc Market Cap for the quarter ending March 03, 2018 was $1,512m a 69.68% increase of 1,053m year over year
  • Iovance Biotherapeutics Inc Price / Book for the quarter ending March 03, 2018 was 8.50 a 64.03% increase of 5.44 year over year
  • Iovance Biotherapeutics Inc Enterprise Value for the quarter ending March 03, 2018 was $1,366m a 77.23% increase of 1,055m year over year
View Chart On Koyfin